Initiation of Antiresorptive Drug Treatment during Endocrine Therapy for Breast Cancer—A Retrospective Cohort Study of 161,492 Patients in Germany

Initiation of Antiresorptive Drug Treatment during Endocrine Therapy for Breast Cancer—A Retrospective Cohort Study of 161,492 Patients in Germany

Endocrine therapy (ET), which significantly reduces breast cancer (BC) recurrence and mortality rates, is the primary systemic therapy for hormone receptor positive BC. However, in addition to frequently reported TAM- and AI-related side effects, such as hot flashes, arthralgias, and myalgias, treat...

Full description

Saved in:
Bibliographic Details
Main Authors: Gremke, Niklas, Griewing, Sebastian, Kadys, Arturas, Kostev, Karel, Wagner, Uwe, Kalder, Matthias
Format: Article
Language:English
Published: Philipps-Universität Marburg 2023
Subjects:
breast cancer
denosumab
tamoxifen
antiresorptive therapy
Germany
Medizin
aromatase inhibitors
bisphosphonates
endocrine therapy
Medical sciences Medicine
Online Access:PDF Full Text
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

PDF Full Text

Holdings details from
Call Number: urn:nbn:de:hebis:04-es2024-02856
Publication Date: 2024-01-15
Source: Erstveröffentlichung: Gremke, N.; Griewing, S.; Kadys, A.; Kostev, K.; Wagner, U.; Kalder, M. Initiation of Antiresorptive Drug Treatment during Endocrine Therapy for Breast Cancer—A Retrospective Cohort Study of 161,492 Patients in Germany. Cancers 2023, 15, 1847. https://doi.org/10.3390/cancers15061847
Downloads: 43 (2024)
License: https://creativecommons.org/licenses/by/4.0
Access URL: https://archiv.ub.uni-marburg.de/es/2024/0285
https://doi.org/10.3390/cancers15061847

Similar Items